Skip to content

HBSC

Active
Private limited company·Activiteiten van medisch specialisten· 4 yrs active
Bostsestraat 61 ·3300 Tienen, Belgium
KBO/BCE: BE 0781.991.531
Watch Print / PDF
Age4 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of HBSC is 0.2% (very low). The 2024 annual accounts show equity of €526k and a net result of €226k. Equity is growing by ~63.3% per year across the filed fiscal years. Its solvency ranks better than 95% of 6573 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Signals

3 signals · with evidence
Strong solvency vs sector
Solvency is in the sector's strongest quartile: better than 95% of 6573 peers (2024). A comfortable equity buffer.
View the sector comparison
Consistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend
Growing equity
Equity grew over 2022-2024. Profits are largely retained rather than distributed.
View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 10 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-06-2025, 31 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 3 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 30-06-2025 31 d early 2025-00194801
31-12-2023 31-07-2024 14-08-2024 14 d late 2024-00343797
31-12-2022 31-07-2023 03-07-2023 28 d early 2023-00207443

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.2% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€226k+47.8%
Working capital€495k+90.9%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 30-06-2025 with the NBB · fiscal year 2024 · micro
€0€100k€200k€300kOperating result 2022: €186k€186kNet result 2022: €143k€143kOperating result 2023: €196k€196kNet result 2023: €153k€153kOperating result 2024: €292k€292kNet result 2024: €226k€226k202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~63.3%/year over 3 fiscal years, indicative, assuming unchanged policy.
€0€250k€500k€750k€1.00M€1.25M2025: €715k (€673k - €757k)2026: €905k (€863k - €947k)2027: €1.09M (€1.05M - €1.14M)2022: €146k2023: €299k2024: €526k202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 99.7% 66.7%
better than 95% of 6573 sector peers
Net result €226k €46k
better than 95% of 6567 sector peers
Equity €526k €79k
better than 95% of 6573 sector peers
Gross operating margin €305k €78k
better than 93% of 6575 sector peers
Total assets €527k €154k
better than 88% of 6576 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P95
2022: P64 · n=36672023: P94 · n=53292024: P95 · n=65732022 2024
Improving position over 2022-2024 · n=3667-6573
Net result P95
2022: P92 · n=36652023: P92 · n=53282024: P95 · n=65672022 2024
Stable position over 2022-2024 · n=3665-6567
Equity P95
2022: P78 · n=36672023: P90 · n=53312024: P95 · n=65732022 2024
Improving position over 2022-2024 · n=3667-6573
Gross operating margin P93
2022: P88 · n=36632023: P89 · n=53252024: P93 · n=65752022 2024
Stable position over 2022-2024 · n=3663-6575
Describes the position versus peers, not a forecast.
EBITDA
€305k
+46.1% 22-24
Net profit
€226k
+47.8% 22-24
Cash flow
€238k
+44.3% 22-24
Total assets
€527k
+66.5% 22-24
Equity
€526k
+75.5% 22-24
Working capital
€495k
+90.9% 22-24
Income taxes
€69k
+53.8% 22-24
Debt
€2k
-89.4% 22-24
Debt ≤ 1y
€2k
-89.4% 22-24
Current ratio
272.75
+1600.2% 22-24
Quick ratio
272.75
+1600.2% 22-24
Solvency
99.7%
+5.4% 22-24
Debt / equity
0.00
-94.0% 22-24
ROE
43.0%
-15.8% 22-24
ROA
42.9%
-11.3% 22-24
Interest coverage
3980.83
+220.7% 22-24
Figures by fiscal year
Fiscal year2024
Depositmicro
Revenue-
EBITDA€305k
Net profit€226k
Cash flow€238k
Staff costs-
Income taxes€69k
Dividends-
Total assets€527k
Equity€526k
Debt€2k
of which ≤ 1y€2k
of which > 1y-
Working capital€495k
Employees (FTE)-
Ratios (computed)
2024
Current ratio272.75
Quick ratio272.75
Working capital ratio93.8%
Solvency99.7%
Debt / equity0.00
Long-term debt ratio-
Interest coverage3980.83
Gross margin-
Net margin-
ROA42.9%
ROE43.0%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€527k
Fixed assets 21/28€31k
Tangible fixed assets 22/27€31k
Current assets 29/58€496k
Amounts receivable within one year 40/41€67k
Cash & bank 54/58€326k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€527k
Equity 10/15€526k
Contributions / capital 10/11€3k
Reserves 13€523k
Amounts payable 17/49€2k
Amounts payable within one year 42/48€2k
Trade debts payable within one year 44€2k
Income statement
Gross operating margin 9900€305k
Operating result 9901€292k
Financial income 75€3k
Financial charges 65€77
Result before taxes 9903€296k
Income taxes 67/77€69k
Net result for the period 9904€226k
Result to be appropriated 9905€226k
You're seeing the latest fiscal year only. Unlock 2 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
100 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Structure & network

Locations & real estate

Establishment units

1 location
HBSC
Stadsomvaart 11, 3500 HasseltActiviteiten van medisch specialisten
since 20222.328.836.673
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels2
Ground area4.1 ha
Buildings2
Building footprint1.2 ha
Volume (LiDAR)2,620 m³
Tallest building14.3 m · ±4 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
71328D0168/00L000 Flanders 4.1 ha 1 · 1.2 ha -
24592E0154/00W000 Flanders 221 m² 1 · 221 m² 14.3 m · 4 fl.
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

1 acts
Address history · 1
17-01-2023
Registered-office move
All acts · 1 updated 3 years ago
2023
17-01-2023 Registered office moved from Leuven to Tienen Registered-office change
  • Brusselsestraat 318 A3, 3000 Leuven, België → Bostsestraat 61 te 3300 Tienen

Analysis

Snowflake analysis

financial profile on 5 axes
Health100Profitability100Solvency100Growth78Stability94
94 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 100
Profitability 100
Solvency 100
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, ranked by comparable size

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Praktijken van specialisten86220Activiteiten van medisch specialisten86220
Primary activity highlighted.
Names & trade names
Legal nameNL HBSC
Registered office
Bostsestraat 61
3300 Tienen, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.